Moderna, Merck say vaccine-drug combo reveals promise in opposition to melanoma
Drugmakers Moderna and Merck say a messenger-RNA vaccine candidate confirmed promise in thwarting melanoma when utilized in mixture with one other drug, Keytruda, in a mid-stage trial.
The corporations on Sunday mentioned almost 79% of part 2 trial members who obtained the vaccine-drug mixture didn't see a...










